Search Results 331-340 of 16588 for ������������KA���:ZA31���24������ ���������������������������������

  1. A Study of Cediranib and Olaparib Combined, Compared to Either Drug Alone, or to a Standard Chemotherapy in Treating Patients who have a Return of Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

    Cediranib maleate and olaparib may stop the growth of tumor cells by blocking enzymes needed for cell growth. Drugs used in chemotherapy work in different ways ...

  2. Whipple procedure - Doctors & Departments - Mayo Clinic

    Accessed March 24, 2023. Reber HA. Surgical resection of lesions of the head of the pancreas. https://www.uptodate.com/contents/search. Accessed March 24, 2023.

  3. Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma - Mayo Clinic

    OR > 200 mg of monoclonal protein in the urine on 24 hour electrophoresis; OR serum immunoglobulin free light chain ≥ 10 mg/dL AND abnormal serum ...

  4. Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma - Mayo Clinic

    Lenalidomide may stimulate the immune system in different ways and stop cancer cells from growing. It is not yet known whether rituximab and combination ...

  5. Whipple procedure - Doctors & Departments - Mayo Clinic

    In: Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 21st ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed March 24, ...

  6. A Study to Evaluate the Safety and Effectiveness of Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients with Crohn's Disease - Mayo Clinic

    ... 24 weeks and a follow-up period up to 52 weeks. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...

  7. Publications - Matthew A. Zarka, M.D. - Mayo Clinic

    ... KA, Lukens JN, Swisher-McClure S, Weinstein GS, O ... 2017; 14:3 Epub 2017 Feb 24. View PubMed ... 2016; 13:24. Epub 2016 Oct 13. View PubMed; Allen ...

  8. Tau PET Outcomes with Anti-amyloid Immunotherapies - Mayo Clinic

    Rochester, Minnesota: 24-004371. NCT ID: NCT06723015. About this study. The purpose of this study is to evaluate change in tau PET in patients receiving anti ...

  9. Cell-Free Dna Epigenomics to Track the Dynamics of Organ Damage and Immune Exhaustion During Sepsis - Mayo Clinic

    Rochester, Minnesota: 24-009707. Sponsor Protocol Number: ROR2401. About this study. The purpose of this study is to quantify cell-free DNA arising from organ ...

  10. Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)

    Jacksonville, Florida: 24-011255; Scottsdale/Phoenix, Arizona: 24-011255. NCT ID: NCT06556654. Sponsor Protocol Number: TBR 22-07. About this study. This record ...